About: covid:arg/0148076f54321df00acc0a55eac1fe191fa08295/6

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:arg/0148076f54321df00acc0a55eac1fe191fa08295/6 Goto Sponge NotDistinct Permalink

An Entity of Type : amo:Evidence, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	sioca:Justification aif:I-node evidence
wasQuotedFrom	Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
sioca:supports	covid:arg/0148076f54321df00acc0a55eac1fe191fa08295/8
aif:formDescription	Neutralising antibodies against live MERS - CoV were observed in four ( 44 % [ 95 % CI 19 - 73 ] ) of nine participants in the high - dose group 28 days after vaccination , and 19 ( 79 % [ 58 - 93 ] ) of 24 participants had antibodies capable of neutralisation in a pseudotyped virus neutralisation assay .
proves	covid:arg/0148076f54321df00acc0a55eac1fe191fa08295/8
is hasSource of	nodeID://b56535376 nodeID://b56574260 nodeID://b56789368 nodeID://b57234524 nodeID://b57987076
is has evidence of	covid:arg/0148076f54321df00acc0a55eac1fe191fa08295

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software